Details of the Drug Formulaction

General Information of Drug Formulation (ID: F05920)

• Formulation Name: Digoxin 0.25 mg tablet
• Company: Aidarex Pharmaceuticals; Jerome Stevens Pharmaceuticals; Lake Eire Medical & Surgical Supply DBA Quality Care Products; Lannett Company; NCS HealthCare of KY, Inc dba Vangard Labs; PD-Rx Pharmaceuticals; St Marys Medical Park Pharmacy; Unit Dose Services

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Digoxin	(DMQCTIH)	Arrhythmia	BC9Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Carmellose sodium	(E00625)	Not Available	Disintegrant
Magnesium stearate	(E00208)	11177	lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Stearic acid	(E00079)	5281	Emulsifying agent; Solubilizing agent; Viscosity-controlling agent; lubricant